Dr Tom C Dawson is a leading consultant paediatrician specialising in allergies, who treats patients privately in Birmingham and Worcester. With over 20 years of experience, Dr Dawson is an expert in the diagnosis, treatment, and management of food allergies, eczema, allergic rhinitis, asthma, and urticaria. Also, he specialises in the administration of immunotherapy.
After earning his bachelor's degree in medicine and surgery from University College, London, Dr Dawson completed junior training, junior paediatric training, and advanced paediatric training in numerous leading hospitals across the country. As a result, he gained specialist experience in allergy and infectious disease, hepatology, rheumatology, and paediatric intensive care. He also completed a year-long position as a clinical fellow and then acting clinical lecturer researching the Meningococcal B vaccine. In 2014, Dr Dawson was awarded his master of science in allergy from Imperial College London.
Since 2009, Dr Dawson has held a position as a consultant paediatrician at the Worcestershire Acute Hospitals NHS Trust. During this period, he has developed and led the trust's paediatric allergy services, establishing diagnostic services and provision of immunotherapy. Additionally, Dr Dawson treats patients privately at MidlandHealth, Birmingham, where it is possible to book a consultation with him on Friday or Saturday mornings, and at Barbourne Health Centre, Worcester. Consultations with Dr Dawson last 45 minutes with testing, or 30 minutes without.
Alongside his clinical work, he is the chair of both the Three Counties Allergy and the Midlands Paediatric Allergy Groups. He remains actively interested in research and has links with Worcester University and is the hospital’s lead paediatric researcher. He has contributed to meetings, both nationally and internationally. He is a member of various renowned bodies, such as his membership of the Royal College of Paediatrics and Child Health (MRCPCH) and the British Society for Allergy and Clinical Immunology (BSACI). He forms part of the BRIT committee overseeing the BRIT registry responsible for monitoring the efficacy of immunotherapy nationwide, and the RCPCH/BSACI Standards Group, which develops national standards for paediatric allergy services.